Success Stories: NAILG Secures NIW Approval for Research Assistant Through USCIS Premium Processing

 

Client’s Testimonial:

“The attorneys and staff at NAILG demonstrated exceptional professionalism, expertise, and dedication throughout the entire process. It was truly a pleasure working with such a competent and supportive team. I am incredibly grateful for their time and effort in securing the approval of my case.”


On October 31st, 2024, we received another EB-2 NIW (National Interest Waiver) approval for a Research Assistant in the Field of Biostatistics (Approval Notice).


General Field: Biostatistics

Position at the Time of Case Filing: Research Assistant

Country of Origin: China

State of Residence at the Time of Filing: Florida

Approval Notice Date: October 31st, 2024

Processing Time: 1 month, 19 days (Premium Processing Requested)


Case Summary:

When a Research Assistant decided to further her research in the United States and file for a National Interest Waiver (NIW) petition, she reached our team for assistance. Leveraging our expertise, we successfully secured her approval by crafting a strong petition that highlighted her qualifications, including the following details:

  • An M.S. in Biostatistics highlights her strong background, meeting the first requirement of the petition as an advanced degree holder.
  • She has a strong record of published works, including 1 paper ranked in the top 1% and 3 papers ranked in the top 10% of the most-cited articles in the field for their respective years.
  • Not only that, her research has also been cited a total of 84 times, indicating that she is a greatly influenced figure in her field.
  • Due to her expertise, she has been invited to conduct peer reviews for a reputable journal in the field, and she has completed at least 1 review so far.
  • We discovered that she wishes to continue her research on developing innovative statistical methodologies that enhance the precision, efficiency, and reliability of clinical trials. Her work aims to improve therapeutic outcomes for patients, reduce the time and costs associated with bringing therapeutic strategies to market, meet safety and efficacy standards, and increase the accessibility of life-saving treatments. Ultimately, her research aims to make the process of getting new treatments to market more efficient, which in turn helps reduce the disease burden in the United States.
  • Furthermore, her research has been supported by the National Institute on Drug Abuse (NIDA), underscoring its significance and national importance.
  • Upon all her remarkable credentials, our client received 2 recommendation letters from fellow experts that strengthened her case. One of the recommenders stated:

“The value of [Client’s] research on harm reduction, syringe services programs, and infectious disease prevention has been quite important, particularly in the context of developing effective health policies amid a global pandemic. Therefore, it is in the best interests of the United States to support [Client’s] ongoing research.”

After 49 days of dedication, our client secured her NIW, thanks to USCIS premium processing. We appreciate her faith in our firm and wish her luck in her coming days.